The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Jump to: Company in focus,
Offsprings
Parent entities and officers
2
- 1
Somers, Michael
Born in April 1970Individual (2 offsprings)Officer2018-09-10 ~ nowOF - Director → CIF 0Mr Michael Somers
Born in April 1970Individual (2 offsprings)Person with significant control2018-09-10 ~ nowPE - Right to appoint or remove directors → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0 - 2
Somers, Natasha
Born in August 1972Individual (3 offsprings)Officer2018-09-10 ~ nowOF - Director → CIF 0Mrs Natasha Somers
Born in August 1972Individual (3 offsprings)Person with significant control2018-09-10 ~ nowPE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
Company in focus
BIOPHARMA CONSULTING LIMITED
Period: 2018-09-10 ~ now
Company number: 11561233
Registered name
BIOPHARMA CONSULTING LIMITED - now
Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Intangible Assets
0 GBP2025-09-30
0 GBP2024-09-30
Property, Plant & Equipment
3,390 GBP2025-09-30
2,091 GBP2024-09-30
Debtors
27,997 GBP2025-09-30
36,042 GBP2024-09-30
Cash at bank and in hand
27,689 GBP2025-09-30
13,507 GBP2024-09-30
Current Assets
55,686 GBP2025-09-30
49,549 GBP2024-09-30
Net Current Assets/Liabilities
-155 GBP2025-09-30
724 GBP2024-09-30
Total Assets Less Current Liabilities
3,235 GBP2025-09-30
2,815 GBP2024-09-30
Net Assets/Liabilities
2,388 GBP2025-09-30
2,292 GBP2024-09-30
Equity
Called up share capital
100 GBP2025-09-30
100 GBP2024-09-30
Retained earnings (accumulated losses)
2,288 GBP2025-09-30
2,192 GBP2024-09-30
Equity
2,388 GBP2025-09-30
2,292 GBP2024-09-30
Average Number of Employees
22024-10-01 ~ 2025-09-30
22023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Gross Cost
Other
8,684 GBP2025-09-30
12,606 GBP2024-09-30
Property, Plant & Equipment - Other Disposals
Other
-7,225 GBP2024-10-01 ~ 2025-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
5,294 GBP2025-09-30
10,515 GBP2024-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
2,004 GBP2024-10-01 ~ 2025-09-30
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Other
-7,225 GBP2024-10-01 ~ 2025-09-30
Property, Plant & Equipment
Other
3,390 GBP2025-09-30
2,091 GBP2024-09-30
Trade Debtors/Trade Receivables
Current
26,858 GBP2025-09-30
28,279 GBP2024-09-30
Other Debtors
Amounts falling due within one year, Current
1,139 GBP2025-09-30
7,763 GBP2024-09-30
Debtors
Amounts falling due within one year, Current
27,997 GBP2025-09-30
36,042 GBP2024-09-30
Trade Creditors/Trade Payables
Current
0 GBP2025-09-30
1,360 GBP2024-09-30
Other Taxation & Social Security Payable
Current
54,404 GBP2025-09-30
43,607 GBP2024-09-30
Other Creditors
Current
1,437 GBP2025-09-30
3,858 GBP2024-09-30
Par Value of Share
Class 1 ordinary share
1 GBP2024-10-01 ~ 2025-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
50 shares2025-09-30
Class 2 ordinary share
50 shares2025-09-30
50 shares2024-09-30
Par Value of Share
Class 2 ordinary share
1 GBP2024-10-01 ~ 2025-09-30
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
50 shares2024-09-30
Equity
Called up share capital
100 GBP2025-09-30
100 GBP2024-09-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
500 GBP2025-09-30
1,000 GBP2024-09-30
Related profiles found in government register
- Registered number 11561233
BIOPHARMA CONSULTING LIMITED
InfoThe Threshing Barn Manor Farm Barns, Coates Lane, High Wycombe, Buckinghamshire HP13 5UXPRIVATE LIMITED COMPANY incorporated on 2018-09-10 (7 years 8 months). The status of the company number is Active.The last date of confirmation statement was made at 2025-09-09CIF 0 BIOPHARMA CONSULTING LIMITED
SRegistered number 11561233The Threshing Barn, Manor Farm Barns, Coates Lane, High Wycombe, Buckinghamshire, United Kingdom, HP13 5UXCIF 1BIOPHARMA CONSULTING LIMITED
SRegistered number 11561233The Threshing Barn, Manor Farm Barns, Cotes Lane, High Wycombe, Buckinghamshire, United Kingdom, HP13 5UXIncorporated in United KingdomCIF 2
Offspring entities and appointments
1
- 1
BIOPHARMA RESEARCH EXPERTS LLP
OC439575The Threshing Barn Manor Farm Barns, Coates Lane, High Wycombe, Buckinghamshire, United KingdomDissolved Corporate (3 parents)Person with significant control2021-10-18 ~ dissolvedCIF 2 - Right to surplus assets - More than 25% but not more than 50% → OECIF 2 - Ownership of voting rights - More than 25% but not more than 50% → OEOfficer2021-10-18 ~ dissolvedCIF 1 - LLP Designated Member → ME
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 22 April 2026 and
licensed under the Open Government Licence v3.0.